Mice Model Market to reach USD 2.7 billion by 2028

"Increasing demand for personalized medicine"

The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the mice model market are its various advantages in the drug discovery sector, and the high efficiency of the technologies. However, the presence of alternative animal research models is expected to restrain market growth to a certain extent.

Download Free Sample PDF @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=272287

The mice model market has been segmented based on model types & services, technology, application, end user, and region.

"By application, the PDx models/ xenografts segment accounted for the largest share of the mice model market"

Based on application, the mice model market is categorized into drug discovery and development, basic research, and PDX models/ xenografts. The PDx models/ xenografts segment dominated the market in 2022, owing to the growing preference for personalized medicine in immunodeficient mice models. Personalized medicines are designed through the use of mice models.

"By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share in the mice model market"

Based on end user, the Mice model market is segmented into academic & research institutions, pharmaceutical & biotechnology companies, contract research organizations (CROs) and contract development & manufacturing organizations. In 2022, the pharmaceutical and biotechnology companies' segment accounted for a larger share of the mice model market. Growth in this market segment can be attributed to the increasing expenditure on R&D by companies for drug development.

"North America: the largest share of the mice model market"

North America accounted for the largest share of the mice model market. The large share of the North America region can be attributed to a rise in the preclinical activities by contract research organizations and the biopharmaceutical companies, and a significant increase in the biomedical research. Moreover, presence of key players in the mice model market in the U.S. are propelling the growth of the market.

"Asia Pacific: The fastest-growing region in the mice model market."

The Asia Pacific mice model market is projected to grow at the highest CAGR during the forecast period. This is attributed to increasing numbers of both domestic and international market players which are focusing on increasing their prescence in the region. Meanwhile, domestic players are expanding their international reach through partnerships, collaborations, agreements, and expansions. Moreover, increasing demand for personalized medicine and regenerative medicine, international alliances for R&D activities in China, and mandatory animal testing for pharmaceutical drugs & cosmetics.

Mice models, an essential tool in biomedical research, have played a pivotal role in advancing our understanding of human health and disease. As technology and genetic engineering techniques progress, the future of mice models promises to revolutionize drug development, personalized medicine, and the study of complex human diseases.

One of the key areas shaping the future of mice models is the development of genetically modified mice. With the advent of CRISPR-Cas9 and other precise gene-editing technologies, scientists can create mice with specific genetic mutations that closely mimic human diseases. These sophisticated models allow researchers to study disease mechanisms and test potential therapies more accurately, ultimately accelerating the development of novel treatments.

Moreover, the future of mice models involves the integration of humanized mice. By implanting human cells, tissues, or even entire immune systems into mice, researchers can create hybrid models that closely resemble human physiology and pathology. Humanized mice hold tremendous potential for studying infectious diseases, cancer, and immune responses, leading to more translational findings and improved therapeutic strategies.

Additionally, the demand for personalized medicine is driving the future of mice models. Patient-derived xenograft (PDX) mice, created by transplanting human tumor tissues into mice, enable individualized drug testing and treatment optimization. PDX mice models hold promise in tailoring therapies to a patient's unique genetic profile, improving treatment outcomes, and reducing the risk of adverse reactions.

Furthermore, mice models are becoming more sophisticated and interconnected with data-driven approaches. Real-time monitoring and integration with electronic health records facilitate continuous data collection, leading to more comprehensive and precise research findings. Combining mice models with advanced analytics will unlock new insights into disease progression and treatment response, enabling more informed clinical decisions.

In conclusion, the future of mice models is marked by innovation, precision, and personalization. As technology and genetic engineering capabilities advance, mice models will continue to be indispensable tools in biomedical research and drug development. These cutting-edge models hold the key to breakthroughs in personalized medicine, disease understanding, and therapeutic interventions, contributing to better health outcomes for patients worldwide.

Download Complete Report @ https://www.reportsnreports.com/purchase.aspx?name=272287

ReportsnReports - Your Market Research Librarian
Corporate Headquarters
Tower B5, office 101, Magarpatta SEZ,
Hadapsar, Pune-411013, India.
+ 1 347 333 3771
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.